Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy
Authors:
- 15 December 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (3) , 815-818
Abstract
No abstract availableFunding Information
- A Shot for Life
- The Jenny Fund
- Swim Across America
- Edward S. Toole Glioblastoma Research Fund
- National Institutes of Health
- National Cancer Institute (R01CA294071)
- William G. Markos Fund for Brain Tumor Immunotherapy
- MGH ECOR Fund for Medical Discovery Research Fellowship Award
- Krantz Family Center for Cancer Research Breakthrough
- Massachusetts Life Sciences Center Research Infrastructure Program
- Mass General Cancer Center Tumor Cartography Center
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
This publication has 4 references indexed in Scilit:
- Redefining CNS immune privilegeNature Reviews Immunology, 2025
- The Clinical TIL Experience in Melanoma: Past, Present, FutureTransplantation and Cellular Therapy, 2025
- Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastasesJournal of Neuro-Oncology, 2020
- Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancerJournal of Experimental Medicine, 2019